DEX

DEXAMETHASONE

Find entries where: DEX

is present as a standalone ligand in 19 entries

Find related ligands:

Chemical Component Summary
Name	DEXAMETHASONE
Synonyms	9A-FLUORO-16BETA-METHYLPREDNISOLONE
Identifiers	(8S,9R,10S,11S,13S,14S,16R,17R)-9-fluoro-11,17-dihydroxy-17-(2-hydroxyethanoyl)-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one
Formula	C₂₂ H₂₉ F O₅
Molecular Weight	392.461
Type	NON-POLYMER
Isomeric SMILES	C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@@]4([C@]3([C@H](C[C@@]2([C@]1(C(=O)CO)O)C)O)F)C
InChI	InChI=1S/C22H29FO5/c1-12-8-16-15-5-4-13-9-14(25)6-7-19(13,2)21(15,23)17(26)10-20(16,3)22(12,28)18(27)11-24/h6-7,9,12,15-17,24,26,28H,4-5,8,10-11H2,1-3H3/t12-,15+,16+,17+,19+,20+,21+,22+/m1/s1
InChIKey	UREBDLICKHMUKA-CXSFZGCWSA-N

Chemical Details
Formal Charge	0
Atom Count	57
Chiral Atom Count	8
Bond Count	60
Aromatic Bond Count	0

Drug Info: DrugBank

DrugBank ID	DB01234
Name	Dexamethasone
Groups	approved investigational vet_approved
Description	Dexamethasone, or MK-125, is a corticosteroid fluorinated at position 9 used to treat endocrine, rheumatic, collagen, dermatologic, allergic, ophthalmic, gastrointestinal, respiratory, hematologic, neoplastic, edematous, and other conditions.[L10701] Developed in 1957, it is structurally similar to other corticosteroids like [hydrocortisone] and [prednisolone].[A188724] Dexamethasone was granted FDA approval on 30 October 1958.[L10695] In a press release for the Randomized Evaluation of COVID-19 Therapy (RECOVERY) trial on 16 June 2020, dexamethasone was recommended for use in COVID-19 patients with severe respiratory symptoms. Dexamethasone reduced deaths by approximately one third in patients requiring ventilation and by one fifth in those requiring oxygen.[L14318]
Synonyms	Dexaméthasone 16alpha-Methyl-9alpha-fluoro-1-dehydrocortisol 9α-Fluoro-16α-methylprednisolone Dexamethasonum 1-Dehydro-16alpha-methyl-9alpha-fluorohydrocortisone 1-Dehydro-16α-methyl-9α-fluorohydrocortisone Dexamethasone 16α-Methyl-9α-fluoro-1-dehydrocortisol Dexamethasone sodium phosphate 9alpha-Fluoro-16alpha-methylprednisolone Dexametasona Dexamethasone phosphate
Brand Names	DEXAMETHASONE 6-Day Odan-dexamethasone Elixir Ciprodex Dexopin Sofracort Sterile Ear/eye Ointment LoCort 7-Day Odan-trol Hexadrol Phosphate Ratio-dexamethasone Ciprofloxacin and Dexamethasone Neomycin and Polymyxin B Sulfates and Dexamethasone Decadron Phosphate Eye Ear Sol 0.1% Ocudex Liq 0.1% ZonaCort 11-Day Decadron Tab 4mg Dexamethasone Sodium Phosphate 0.1% / Finasteride 0.1% / Minoxidil 5% / Tretinoin 0.025% PMS-dexamethasone Ropidex Apo-dexamethasone ReadySharp Anesthetics plus Dexamethasone Dexamethasone Intensol Cresophene Liq Ciprofloxacin and dexamethasone Mardex 25 Kit Zcort Cushings Syndrome Diagnostic Pro-dexamethasone - 4 Dom-dexamethasone Tablet 4mg Dexamethasone Sodium Phosphate 0.1% / Finasteride 0.1% / Minoxidil 5% Dexamethasone Sodium Phosphate Injection Sdz Dexamethasone Sodium Phosphate Injection, USP Tobramycin and dexamethasone Dexamethasone Omega Unidose Dexasone 4mg Accufix II Dec Model 033-212 Encor Dec Model 033-448 Imp 0.5mg/imp Cortaren Corticosteroid/Anti-Inflammatory System Dexamethasone Sod Phos Inj 4mg/ml Hexadrol Phosphate Inj 10mg/ml Viadox Encor Dec Model 033-757 Imp 0.5mg/imp Neomycin Sulfate, Polymyxin B Sulfate and Dexamethasone R.O.-dexsone Decadron Tobramycin and Dexamethasone Dmt Suik DEXAMETHASONE Sodium Phosphate Dexlido-M Kit Dioptrol Ointment Encor Dec Model 033-443 Imp 0.5mg/imp Ozurdex HiDex 6-day Neofordex Dexamethasone Sodium Phosphates Decadron Tab 0.5mg Dioptrol Suspension Encor Dec Model 033-159 Imp 0.5mg/imp Npd TaperDex 7-day Neomycin Polymyxin B Sulfates and Dexamethasone Dexamethasone Tobradex ST Dextenza TaperDex 12-day Dexamethsone Sandoz Ciprofloxacin / Dexamethasone Neuromaquel Neuroma/Anti-Inflammatory System TobraDex Dexabliss Dexasone 0.5mg Levodexa Dex-Moxi-Ketor Neo-poly-dex Gati-Dex DexMoxiKetor PF ReadySharp Dexamethasone PMS-dexamethasone Sod Phosphate Inj 4mg/ml Dex-Moxi Dexamethasone 1.5 mg Neo/Poly-B/Dex Ophth Oint Encor Dec Model 033-856 Imp 0.5mg/imp 999 Itch Relief Netildex Dexlido Kit Taro-ciprofloxacin/dexamethasone Dexamethasone Sodium Phosphate Dexamethasone Tablets Sandoz Dexamethasone AK-Trol PMS-dexamethasone Sod Phosphate Dps 1mg/ml LoCort 11-Day Maxitrol Ratio-dexamethasone Tablets, USP PMS-dexamethasone Sod Phosphate Inj 10mg/ml Dexamethasone Sod Phosph Inj 10mg/ml USP Maxidex Ludaxine TaperDex 6-day Dexycu Dexamethasone Unidose Hemady Dex-Moxi PF Dexamethasone-omega Zema Pak Mas Care-pak Dexamethasone ZonaCort 7-Day Sofracort Ear/eye Ointment Sandoz Tobramycin / Dexamethasone PMS-dexamethasone Elixir Dexamethasone Sodium Phosphate Inj USP 4mg/ml Dxevo Hexadrol Phosphate Inj 4mg/ml Neodecadron Eye Ear Soln 0.1% Decadron Phosphate Inj 4mg/ml DoubleDex Kit TopiDex Methedex ZoDex Decadron DP Odan-dexamethasone Tobradex Dexasone 0.75mg Dexamethasone Sodium Phosphate 0.1% PHL-dexamethasone Baycadron
Indication	Dexamethasone and [ciprofloxacin] otic suspension is indicated for bacterial infections with inflammation in acute otitis media and acute otitis externa.[L10698] Intramuscular and intravenous injections are indicated for a number of endocrine, rheumatic, collagen, dermatologic, allergic, ophthalmic, gastrointestinal, respiratory, hematologic, neoplastic, edematous, and other conditions.[L10701] Oral tablets are indicated for the treatment of multiple myeloma.[L10710] An intravitreal implant is indicated for some forms of macular edema and non-infectious posterior uveitis affecting the posterior of the eye.[L10719] Various ophthalmic formulations are indicated for inflammatory conditions of the eye.[L10704,L10707,L10713,L10716,L10722,L10725]
Categories	Adrenal Cortex Hormones Adrenals Agents Causing Muscle Toxicity Agents for Treatment of Hemorrhoids and Anal Fissures for Topical Use Alimentary Tract and Metabolism Anti-Acne Preparations Anti-Acne Preparations for Topical Use Anti-Inflammatory Agents Antiemetics Antineoplastic Agents Antineoplastic Agents, Hormonal Autonomic Agents BCRP/ABCG2 Inhibitors BSEP/ABCB11 inducers Central Nervous System Agents Corticosteroid Hormone Receptor Agonists Corticosteroids Corticosteroids for Local Oral Treatment Corticosteroids for Systemic Use Corticosteroids for Systemic Use, Plain Corticosteroids, Dermatological Preparations Corticosteroids, Moderately Potent (Group II) Cytochrome P-450 CYP2A6 Inducers Cytochrome P-450 CYP2B6 Inducers Cytochrome P-450 CYP2B6 Inducers (strength unknown) Cytochrome P-450 CYP2C19 Inducers Cytochrome P-450 CYP2C19 Inducers (strength unknown) Cytochrome P-450 CYP2C8 Inducers Cytochrome P-450 CYP2C8 Inducers (strength unknown) Cytochrome P-450 CYP2E1 Inducers Cytochrome P-450 CYP2E1 Inducers (strength unknown) Cytochrome P-450 CYP3A Inducers Cytochrome P-450 CYP3A Inducers (strong) Cytochrome P-450 CYP3A Inhibitors Cytochrome P-450 CYP3A Substrates Cytochrome P-450 CYP3A4 Inducers Cytochrome P-450 CYP3A4 Inducers (moderate) Cytochrome P-450 CYP3A4 Inducers (strong) Cytochrome P-450 CYP3A4 Inhibitors Cytochrome P-450 CYP3A4 Inhibitors (weak) Cytochrome P-450 CYP3A4 Substrates Cytochrome P-450 CYP3A5 Inducers Cytochrome P-450 CYP3A5 Inducers (moderate) Cytochrome P-450 CYP3A5 Substrates Cytochrome P-450 CYP3A7 Inducers Cytochrome P-450 CYP3A7 Inducers (strength unknown) Cytochrome P-450 CYP3A7 Substrates Cytochrome P-450 Enzyme Inducers Cytochrome P-450 Enzyme Inhibitors Cytochrome P-450 Substrates Dermatologicals Experimental Unapproved Treatments for COVID-19 Fused-Ring Compounds Gastrointestinal Agents Hormones Hormones, Hormone Substitutes, and Hormone Antagonists Hyperglycemia-Associated Agents Immunosuppressive Agents Inducers of Drug Clearance Nasal Preparations OAT3/SLC22A8 Substrates Ophthalmological and Otological Preparations Ophthalmologicals Otologicals P-glycoprotein inducers P-glycoprotein inhibitors P-glycoprotein substrates Peripheral Nervous System Agents Pregnadienes Pregnadienetriols Pregnanes Sensory Organs Steroids Steroids, Fluorinated Stomatological Preparations Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins Vasoprotectives
ATC-Code	R01AD53 D07XB05 R01AD03 D10AA03 S01CB01 S02CA06 S03CA01 C05AA09 S01CA01 D07CB04 H02AB02 S01BA01 A01AC02 S03BA01 D07AB19 S02BA06
CAS number	50-02-2

Drug Targets

Name	Target Sequence	Pharmacological Action	Actions
Glucocorticoid receptor	MDSKESLTPGREENPSSVLAQERGDVMDFYKTLRGGATVKVSASSPSLAV...	unknown	agonist
Nuclear receptor subfamily 0 group B member 1	MAGENHQWQGSILYNMLMSAKQTRAAPEAPETRLVDQCWGCSCGDEPGVG...	unknown	stimulator
Annexin A1	MAMVSEFLKQAWFIENEEQEYVQTVKSSKGGPGSAVSPYPTFNPSSDVAA...	unknown	agonist
Nitric oxide synthase, inducible	MACPWKFLFKTKFHQYAMNGEKDINNNVEKAPCATSSPVTQDDLQYHNLS...	unknown	negative modulator
Nuclear receptor subfamily 1 group I member 2	MEVRPKESWNHADFVHCEDTESVPGKPSVNADEEVGGPQICRVCGDKATG...	unknown	agonist
Corticosteroid 11-beta-dehydrogenase isozyme 2	MERWPWPSGGAWLLVAARALLQLLRSDLRLGRPLLAALALLAALDWLCQR...	unknown	substrate
Cytochrome P450 3A4	MALIPDLAMETWLLLAVSLVLLYLYGTHSHGLFKKLGIPGPTPLPFLGNI...	unknown	substrate,inhibitor,inducer
Corticosteroid 11-beta-dehydrogenase isozyme 1	MAFMKKYLLPILGLFMAYYYYSANEEFRPEMLQGKKVIVTGASKGIGREM...	unknown	substrate
Cytochrome P450 3A5	MDLIPNLAVETWLLLAVSLVLLYLYGTRTHGLFKRLGIPGPTPLPLLGNV...	unknown	substrate,inducer
Cytochrome P450 3A7	MDLIPNLAVETWLLLAVSLILLYLYGTRTHGLFKKLGIPGPTPLPFLGNA...	unknown	substrate,inducer
Steroid 17-alpha-hydroxylase/17,20 lyase	MWELVALLLLTLAYLFWPKRRCPGAKYPKSLLSLPLVGSLPFLPRHGHMH...	unknown	inhibitor
Cytochrome P450 1A1	MLFPISMSATEFLLASVIFCLVFWVIRASRPQVPKGLKNPPGPWGWPLIG...	unknown	inhibitor,inducer
Cytochrome P450 2A6	MLASGMLLVALLVCLTVMVLMSVWQQRKSKGKLPPGPTPLPFIGNYLQLN...	unknown	inducer
Cytochrome P450 2B6	MELSVLLFLALLTGLLLLLVQRHPNTHDRLPPGPRPLPLLGNLLQMDRRG...	unknown	inducer
Cytochrome P450 2C19	MDPFVVLVLCLSCLLLLSIWRQSSGRGKLPPGPTPLPVIGNILQIDIKDV...	unknown	inducer
Cytochrome P450 2C8	MEPFVVLVLCLSFMLLFSLWRQSCRRRKLPPGPTPLPIIGNMLQIDVKDI...	unknown	inducer
Cytochrome P450 2E1	MSALGVTVALLVWAAFLLLVSMWRQVHSSWNLPPGPFPLPIIGNLFQLEL...	unknown	inducer
Cytochrome P450 3A43	MDLIPNFAMETWVLVATSLVLLYIYGTHSHKLFKKLGIPGPTPLPFLGTI...	unknown	inducer
Cytochrome P450 4A11	MSVSVLSPSRLLGDVSGILQAASLLILLLLLIKAVQLYLHRQWLLKALQQ...	unknown	inducer
Cytochrome P450 11B1, mitochondrial	MALRAKAEVCMAVPWLSLQRAQALGTRAARVPRTVLPFEAMPRRPGNRWL...	unknown	inhibitor
Serum albumin	MKWVTFISLLFLFSSAYSRGVFRRDAHKSEVAHRFKDLGEENFKALVLIA...	unknown	binder
P-glycoprotein 1	MDLEGDRNGGAKKKNFFKLNNKSEKDKKEKKPTVSVFSMFRYSNWLDKLY...	unknown	substrate,inhibitor,inducer
Solute carrier family 22 member 8	MTFSEILDRVGSMGHFQFLHVAILGLPILNMANHNLLQIFTAATPVHHCR...	unknown	substrate
Bile salt export pump	MSDSVILRSIKKFGEENDGFESDKSYNNDKKSRLQDEKKGDGVRVGFFQL...	unknown	inducer
Canalicular multispecific organic anion transporter 1	MLEKFCNSTFWNSSFLDSPEADLPLCFEQTVLVWIPLGYLWLLAPWQLLH...	unknown	inducer
ATP-binding cassette sub-family G member 2	MSSSNVEVFIPVSQGNTNGFPATASNDLKAFTEGAVLSFHNICYRVKLKS...	unknown	inhibitor
Solute carrier organic anion transporter family member 1A2	MGETEKRIETHRIRCLSKLKMFLLAITCAFVSKTLSGSYMNSMLTQIERQ...	unknown	inhibitor
View More

Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682